fingolimod hydrochloride has been researched along with Hypertension, Pulmonary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, K; Cui, Y; Feng, J; Fujiwara, A; Go, T; Hiraishi, K; Hirano, K; Inoue, R; Ishikawa, K; Kurahara, LH; Ohga, S; Okada, Y; Onitsuka, M; Satoh, T; Yahiro, E; Yamamura, A; Yokomise, H; Yokota, N; Yue, L | 1 |
| Halank, M; Schrötter, H; Thomas, K; Ziemssen, T | 1 |
2 other study(ies) available for fingolimod hydrochloride and Hypertension, Pulmonary
| Article | Year |
|---|---|
Substantial involvement of TRPM7 inhibition in the therapeutic effect of Ophiocordyceps sinensis on pulmonary hypertension.
Topics: Animals; Cell Proliferation; Cells, Cultured; Cordyceps; Disease Models, Animal; Fingolimod Hydrochloride; Gene Knockdown Techniques; Humans; Hypertension, Pulmonary; Male; Medicine, Chinese Traditional; Mice; Mice, Knockout; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Pulmonary Artery; Rats; Rats, Sprague-Dawley; STAT3 Transcription Factor; Translational Research, Biomedical; TRPM Cation Channels; Vasodilation | 2021 |
Fingolimod in a patient with heart failure on the background of pulmonary arterial hypertension and coronary artery disease.
Topics: Coronary Artery Disease; Female; Fingolimod Hydrochloride; Heart Failure; Humans; Hypertension, Pulmonary; Immunosuppressive Agents; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Propylene Glycols; Sphingosine | 2014 |